Papillomavirus Infections: all 505 studies

Page 4 of 6. Open to participants first (128), then studies with results posted, then the rest; newest registration first within each.

• Promoting HPV Vaccination Among Young Adults in TexasActive, not recruitingNCT05057312Not applicable
• Acceptability of Human Papillomavirus Self-sampling in Women Living With HIVStatus unknownNCT05026047Not applicable
• Characteristics of Vaginal and Intestinal Microbiota and Cervical HPV InfectionActive, not recruitingNCT05003505
• HPV Vaccination in HIV Infected and HIV Uninfected Adolescents in EswatiniCompletedNCT04982614Phase 4
• Post-treatment Surveillance in HPV+ Oropharyngeal SCCActive, not recruitingNCT04965792
• Lot Consistency Clinical Trial of Bivalent HPV Vaccine in 9 to 30 Years Old Healthy FemalesCompletedNCT04965350Phase 3
• A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 YearsStatus unknownNCT04921111Phase 1
• Prevalence and Longitudinal Follow-up of Anal Lesions, HPV Infection and Associated Sexually Transmitted Infections Among Men Who Have Sex With Men in Togo.Status unknownNCT04910438
• HPV Prevalence in Transpersons - a Prospective StudyCompletedNCT04864951Not applicable
• The Study for the "Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa"Active, not recruitingNCT04794660Phase 3
• Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory PapillomatosisActive, not recruitingNCT04724980Phase 1/2
• Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and BoysCompletedNCT04711265
• Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)Active, not recruitingNCT04708041Phase 3
• HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter StudyCompletedNCT04694495
• Changes in the Prevalence of Oncogenic HPV TypesStatus unknownNCT04671823
• Papilocare®: Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and ToleranceCompletedNCT04624568Not applicable
• Prime-boost Vaccine Study in Women With Low-grade Cervical HPV LesionsCompletedNCT04607850Phase 1/2
• HPV Vaccine Immunity in High-risk WomenCompletedNCT04590521Phase 4
• BS-FU01 Follow-Up Study of FluBHPVE6E7 Study SubjectsCompletedNCT04528407
• Study of FluBHPVE6E7 in HPV-16 Infected WomenCompletedNCT04490512Phase 1
• Nabothian Cyst Protects or Facilitates Against Cervical CancerStatus unknownNCT04488991
• HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved AdultsCompletedNCT04474821Phase 4
• Study of the Impact of a School Program Combining - Promotion of HPV Vaccination and HPV Vaccine Offer in Middle School - on Adherence to HPV Vaccination in Middle School StudentsCompletedNCT04459221Phase 4
• HPV Vaccination Health-promotion Programme on Vaccine Acceptance and Uptake Among Female AdolescentsCompletedNCT04438291Not applicable
• Immunogenicity AND Safety Study of the 11 Valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha)CompletedNCT04436133Phase 2
• HPV Vaccine in Postpartum WomenWithdrawnNCT04430907
• Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine SamplesCompletedNCT04391647
• Colposcopy Findings Among Women With High Risk HPV Other Than HPV 16/18 and Normal CytologyCompletedNCT04369339Not applicable
• HPV Genotyping by DR. HPV Genotyping in Vitro Diagnostic Device (IVD) Kit in Exfoliated Cells of the Uterine CervixCompletedNCT04333212Not applicable
• HPV Prevalence in 16-20 Year Old MalesStatus unknownNCT04297670
• Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV TreatmentsTerminatedNCT04278326Not applicable
• Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive WomenActive, not recruitingNCT04270773Phase 4
• Nine-valent HPV Vaccine to Prevent Persistent Oral HPV Infection in Men Living With HIVActive, not recruitingNCT04255849Phase 3
• Intradermal, Fractional Dose of HPV Vaccines:Active, not recruitingNCT04235257Phase 4
• Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPVCompletedNCT04210336Not applicable
• An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination RegimenActive, not recruitingNCT04206813Phase 4
• Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)Active, not recruitingNCT04199689Phase 3
• Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.CompletedNCT04199260
• Clinical Trial to Explore Papilocare Gel Efficacy to Repair of the Cervico-vaginal Mucosa With HPV High Risk Lesions.CompletedNCT04199078Not applicable
• Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.Status unknownNCT04171505
• Impact of HPV Vaccination on Cervical High Grade Lesions in FranceCompletedNCT04167501
• Re-Evaluation of Annual Cytology Using HPV Testing to Upgrade Prevention in Women Living With HIVCompletedNCT04155294
• Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive MenWithdrawnNCT04142398
• HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal SwabsCompletedNCT04133610Not applicable
• Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04124198Not applicable
• Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With PterygiumCompletedNCT04117386
• Conservative Management in Patients Diagnosed With Grade 2 or Grade 3 CINStatus unknownNCT04115787
• A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 YearsCompletedNCT04083196Phase 1
• Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the CervixCompletedNCT04072913Not applicable
• A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal CancerWithdrawnNCT04044950Phase 2
• Clinical Trial to Explore the Papilocare Gel Efficacy to Repair the Cervico-vaginal Mucosa With Lesions Caused by HPVCompletedNCT04002154Not applicable
• Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge)CompletedNCT04000503Not applicable
• Efficacy, Immunogenicity and Safety of V503 in Chinese Women Aged 20-45 Years (V503-023)Active, not recruitingNCT03998254Phase 3
• A Cohort Study for the Following up of ConizationStatus unknownNCT03961178
• A Study of Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female SubjectsCompletedNCT03929172Phase 1
• A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant VaccineCompletedNCT03900572Phase 1
• Persistent Cervical HPV Infection With Clearance and Vaginal MicrobiotaStatus unknownNCT03895866
• Knowledge and Attitudes Towards Human Papillomavirus Infections and HPV VaccinationCompletedNCT03888599
• Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination in Integrated Healthcare Delivery SystemsWithdrawnNCT03887793Not applicable
• Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot StudyStatus unknownNCT03813576Not applicable
• Evaluation of Triage Options After HPV Testing for Cervical Cancer Screening Among HIV-infected WomenStatus unknownNCT03789513Not applicable
• Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCsCompletedNCT03726151Not applicable
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionTerminatedNCT03677960Phase 1
• The KEN SHE Study on HPV-vaccine EfficacyActive, not recruitingNCT03675256Phase 4
• Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus EsophagealCompletedNCT03584308Phase 2
• The Standard Management of HPV InfectionStatus unknownNCT03577925
• Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus InfectionStatus unknownNCT03548740
• Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void UrineCompletedNCT03542227
• Video-Assisted Counseling for HPV VaccinationCompletedNCT03510091Not applicable
• Prevalence of HPV Infection Using Self-samplingCompletedNCT03474211
• Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP)Status unknownNCT03465280
• Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With MenWithdrawnNCT03445416Not applicable
• Quality Improvement Strategies to Increase Human Papillomavirus (HPV) VaccinationCompletedNCT03442062Not applicable
• Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)Active, not recruitingNCT03391921Phase 4
• E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSMStatus unknownNCT03357991
• Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionCompletedNCT03346915Not applicable
• Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in BotswanaCompletedNCT03345875Not applicable
• Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT StudyActive, not recruitingNCT03309033
• A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal WandStatus unknownNCT03302858Phase 2
• Adjuvant Anal Imiquimod Therapy in Anal HPV-lesions: AdAM-trialStatus unknownNCT03289260Phase 3
• HPV Vaccination in Women With Cystic FibrosisCompletedNCT03265743
• A Pilot Study on HPV and Cervical Cancer Screening in MumbaiStatus unknownNCT03229603Not applicable
• Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) InfectionCompletedNCT03202992Phase 1
• Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO StudyActive, not recruitingNCT03180034Phase 4
• A Phase I Trial of LY3143921 Hydrate in Solid TumoursCompletedNCT03096054Phase 1
• A Phase I Study of Quadrivalent HPV Recombinant VaccineCompletedNCT03085381Phase 1
• HPV Infections, Cancer of the Vulva and Therapeutical SuccessCompletedNCT03082950
• HPV Infection and Cervical Neoplasm in Women With Inflammatory Bowel Disease: a Cross-sectional StudyStatus unknownNCT03055130
• Anal HPV Infection and Risk for Anal High-grade Squamous Intraepithelial Lesion Among Thai MSM With Acute HIV InfectionCompletedNCT03032575Not applicable
• Human Papillomavirus in Young People Epidemiological Research 2 (HYPER2)CompletedNCT03000933
• Throat and Other HPV-Related Cancers in Men: Identifying Them EarlyActive, not recruitingNCT02897427
• Community and Physician Perspectives Regarding Male Youth Human Papillomavirus (HPV) Disease and VaccinationCompletedNCT02897232
• Human Papillomavirus Anal InfectionCompletedNCT02862795Not applicable
• Safety Study of EF-022 in Adults With Recurrent Respiratory Papillomatosis (RRP)Status unknownNCT02854761Phase 1
• PApillomavirus in REnal Transplant PatientCompletedNCT02845739Not applicable
• Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With MenActive, not recruitingNCT02816879Not applicable
• The HPV Self-test as a Test of Cure in MadagascarCompletedNCT02811367Not applicable
• Epidemiology of High-risk HPV Infection in Women Participating in a Pilot Screening Program for Cervical CancerCompletedNCT02809352
• A Comparison of Cotton and Flocked Swabs for Vaginal Self CollectionCompletedNCT02785289Not applicable
• Agreement Between Oral and Cervical Human Papillomavirus Infection in a French CohortCompletedNCT02774538Not applicable

← Papillomavirus Infections overview